María Blanca Sánchez

María Blanca Sánchez

Auto-generated profile, based on publicly available information

María Blanca Sánchez

Departamento de Biotecnología Microbiana, Centro Nacional de Biotecnología, CSIC, Cantoblanco, Madrid, Spain

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2016 in Microorganisms
Verified
Journal Article
Open access
PDF file
PBPaula Blanco
Paula Blanco
SHSara Hernando-Amado
Sara Hernando-Amado
JRJose Antonio Reales-Calderon
Jose Antonio Reales-Calderon
FPFernando Corona Pajares
Fernando Corona Pajares
FLFelipe Lira
Felipe Lira
JMJose Martinez
Jose Martinez
Bacterial multidrug efflux pumps are antibiotic resistance determinants present in all microorganisms. With few exceptions, they are chromosomally encoded and present a conserved organization both at the genetic and at the protein levels. In addition, most, if not all, strains of a given bacterial species present the same chromosomally-encoded efflux pumps. Altogether this indicates that multidrug efflux pumps are ancient elements encoded in bacterial genomes long before the recent use of antibiotics for human and animal therapy. In this regard, it is worth mentioning that efflux pumps can extrude a wide range of substrates that include, besides antibiotics, heavy metals, organic pollutants, plant-produced compounds, quorum sensing signals or bacterial metabolites, among others. In the current review, we present information on the different functions that multidrug efflux pumps may have for the bacterial behaviour in different habitats as well as on their regulation by specific signals. Since, in addition to their function in non-clinical ecosystems, multidrug efflux pumps contribute to intrinsic, acquired, and phenotypic resistance of bacterial pathogens, the review also presents information on the search for inhibitors of multidrug efflux pumps, which are currently under development, in the aim of increasing the susceptibility of bacterial pathogens to antibiotics.

1 March 2009 in FEMS Microbiology Reviews
Verified
Journal Article
Closed access
JMJose Martinez
Jose Martinez
MSMaría Blanca Sánchez
María Blanca Sánchez
LMLaura Martínez-Solano
Laura Martínez-Solano
AHAlvaro Hernandez
Alvaro Hernandez
LGLeonor Garmendia
Leonor Garmendia
CACarolina Alvarez-Ortega
Carolina Alvarez-Ortega

1 January 2009 in FEMS Microbiology Reviews
Verified
Journal Article
Open access
JMJose Martinez
Jose Martinez
AFAlicia Fajardo
Alicia Fajardo
LGLeonor Garmendia
Leonor Garmendia
AHAlvaro Hernandez
Alvaro Hernandez
JLJuan Francisco Linares
Juan Francisco Linares
MSMaría Blanca Sánchez
María Blanca Sánchez
Antibiotic resistance is one of the few examples of evolution that can be addressed experimentally. The present review analyses this resistance, focusing on the networks that regulate its acquisition and its effect on bacterial physiology. It is widely accepted that antibiotics and antibiotic resistance genes play fundamental ecological roles - as weapons and shields, respectively - in shaping the structures of microbial communities. Although this Darwinian view of the role of antibiotics is still valid, recent work indicates that antibiotics and resistance mechanisms may play other ecological roles and strongly influence bacterial physiology. The expression of antibiotic resistance determinants must therefore be tightly regulated and their activity forms part of global metabolic networks. In addition, certain bacterial modes of life can trigger transient phenotypic antibiotic resistance under some circumstances. Understanding resistance thus requires the analysis of the regulatory networks controlling bacterial evolvability, the physiological webs affected and the metabolic rewiring it incurs.

30 June 2015 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
MSMaría B. Sánchez
María B. Sánchez
Stenotrophomonas maltophilia is an environmental bacterium found in the soil, associated with plants and animals, and in aquatic environments. It is also an opportunistic pathogen now causing an increasing number of nosocomial infections. The treatment of S. maltophilia is quite difficult given its intrinsic resistance to a number of antibiotics, and because it is able to acquire new resistances via horizontal gene transfer and mutations. Certainly, strains resistant to quinolones, cotrimoxale and/or cephalosporins - antibiotics commonly used to treat S. maltophilia infections - have emerged. The increasing number of available S. maltophilia genomes has allowed the identification and annotation of a large number of antimicrobial and heavy metal resistance genes. Most encode inactivating enzymes and efflux pumps, but information on their role in intrinsic and acquired resistance is limited. Non-typical antibiotic resistance mechanisms that also form part of the intrinsic resistome have been identified via mutant library screening. These include non-typical antibiotic resistance genes, such as bacterial metabolism genes, and non-inheritable resistant phenotypes, such as biofilm formation and persistence. Their relationships with resistance are complex and require further study.

1 September 2016 in Drug Resistance Updates
Verified
Journal Article
Closed access
SHSara Hernando-Amado
Sara Hernando-Amado
PBPaula Blanco
Paula Blanco
MAManuel Alcalde-Rico
Manuel Alcalde-Rico
FCFernando Corona
Fernando Corona
JRJose A. Reales-Calderón
Jose A. Reales-Calderón
JMJose Martinez
Jose Martinez

1 January 2013 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
JOJorge Olivares
Jorge Olivares
ABAlejandra Bernardini
Alejandra Bernardini
GGGuillermo Garcia-Leon
Guillermo Garcia-Leon
FPFernando Corona Pajares
Fernando Corona Pajares
MSMaria B. Sanchez
Maria B. Sanchez
JMJose Martinez
Jose Martinez
Intrinsically resistant bacteria have emerged as a relevant health problem in the last years. Those bacterial species, several of them with an environmental origin, present naturally a low-level susceptibility to several drugs. It has been proposed that intrinsic resistance is mainly the consequence of the impermeability of cellular envelopes, the activity of multidrug efflux pumps or the lack of appropriate targets for a given family of drugs. However, recently published articles indicate that the characteristic phenotype of susceptibility to antibiotics of a given bacterial species depends on the concerted activity of several elements, what has been named as intrinsic resistome. These determinants comprise not just classical resistance genes. Other elements, several of them involved in basic bacterial metabolic processes, are of relevance for the intrinsic resistance of bacterial pathogens. In the present review we analyse recent publications on the intrinsic resistomes of Escherichia coli and Pseudomonas aeruginosa. We present as well information on the role that global regulators of bacterial metabolism, as Crc from P. aeruginosa, may have on modulating bacterial susceptibility to antibiotics. Finally, we discuss the possibility of searching inhibitors of the intrinsic resistome in the aim of improving the activity of drugs currently in use for clinical practice.